January 3, 2018 / 2:09 PM / Updated 10 minutes ago BRIEF-Ligand Earns $6 Million As Omniab Partner Out-Licenses Antibody Projects Reuters Staff 
Jan 3 (Reuters) - Ligand Pharmaceuticals Inc: 
* LIGAND EARNS $6 MILLION AS OMNIAB PARTNER OUT-LICENSES ANTIBODY PROJECTS * SEES FY 2017 ADJUSTED EARNINGS PER SHARE $3.13 TO $3.16 
* SEES FY 2017 REVENUE ABOUT $140 MILLION Source text for Eikon: Further company coverage: